Healthcare

Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Research Report

Posted on Updated on

Allied Market Research added new research report on “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market” includes Industry Size, Share, Trends, Growth, Demand, Supply, Market Development, Analysis and Forecast

Percutaneous transluminal coronary angioplasty (PTCA) is a minimally-invasive procedure used to open blocked or narrowed coronary arteries. PTCA balloons are inflated inside a blocked coronary artery to open up the blockage and allow smooth blood flow. The use of PTCA balloon catheters is on a continuous rise, as it ensures sufficient plaque removal, and optimum patient comfort through a minimally invasive procedure.

Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/2635

Increase in aging population and changes in lifestyle of people, technological advancements, changes in FDA policy, and rise in prevalence of cardiovascular disorders are expected to drive the market growth. However, availability of alternative therapies, and complications associated with PTCA balloon catheters restrain this growth. The upsurge in demand for minimally invasive surgeries, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.

The normal balloon catheter segment is expected to maintain its dominant position during the analysis period, owing to reduced complications associated with them when compared to other product types. The drug eluting balloon catheter segment is expected to grow at a rapid CAGR of 4.7% throughout the forecast period.

There has been an increased use of drug-eluting balloons in the past few years. The use of drug-eluting balloons has resulted in the reduction in the use of vessel implants (such as stents), which may cause vessel fracture. In addition, drug-eluting balloons are safe and they provide the highest rate of restoration of normal blood flow when compared to other balloon catheters.

Browse Full Report @ https://www.alliedmarketresearch.com/percutaneous-transluminal-coronary-angioplasty-PTCA-balloon-catheters-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Nurture is as important as nature when it comes to IVF, scientists find…

Posted on Updated on

UK IVF Services Market

According to a new report published by Allied Market Research titled, UK IVF Services Market by End User and Cycle Type: Opportunity Analysis and Industry Forecast, 2014-2022, the UK IVF services market is estimated to reach $685.4 million by 2022, registering a CAGR of 7.7% from 2016 to 2022.

Early Buyers will receive 20% customization on this report.

The UK IVF services market is characterized by important factors such as increase in cases of infertility, delayed marriages, and parenthood decisions. In addition, decrease in birthrate also boost the market growth. For instance, in 2014 total fertility rate decreased to 1.83 per woman from 1.85 in 2013. The IVF services market in the UK is anticipated to experience a continuous growth due to supportive regulatory bodies such as Human Fertilization and Embryo authority (HFEA), which closely regulates the functioning of IVF treatments and research involving human embryos in the UK supplements the market growth. The growth of the market is associated with decrease in birthrate, increase in infertility, and supportive regulations for IVF treatments.

Sample Report, Click Here!!

The fertility clinics segment is anticipated to dominate the market during the forecast period in terms of volume and revenue. This is because the fertility clinics provide technologically advanced and wide range of fertility treatments under one roof for patients.

Key Findings of the UK IVF Services Market:

  • Based on cycle type, fresh IVF cycles (non-donor) is projected to be one of the fastest growing segment at a CAGR of 8.3% from 2016 to 2022, in terms of revenue
  • Based on end users, fertility clinics is projected to be the one of the fastest growing segment at a CAGR of 8.9% from 2016 to 2022, in terms of revenue
  • Based on cycle type, fresh IVF cycle (non-donor) is projected to be the one of the fastest growing segment at a CAGR of 7.6% from 2016 to 2022, in terms of volume
  • Based on end users, fertility clinics is projected to be the one of the fastest growing segment at a CAGR of 8.2% from 2016 to 2022, in terms of volume

Key players in the UK IVF services market includes companies, hospitals, surgical centers, fertility centers, and clinical research institutes. These includes Lister Fertility Clinics, The Bridge center, and Chelsea and Westminster Hospital.

Bioburden Testing Market – Development, Key Opportunities

Posted on Updated on

Bioburden Testing

Bioburden testing is a process of measuring viable microorganisms on medical devices, raw material, or package. The process helps in determining parameters for its sterilization process to ensure safety and effectiveness of medical devices. It further aids in routine monitoring of raw material, components, and assembly processes in manufacturing process. The bioburden testing is used for assessment of cleaning processes and packaging of products is conducted to ensure safety.

Click here to request sample copy of report: https://www.alliedmarketresearch.com/request-toc-and-sample/928

Growth in the medical devices, pharmaceutical and rising product recalls due to microbial contamination are factors that drive the growth of the world bioburden testing market. In addition, biotechnology industries and increasing food & beverage safety concerns supplements growth. However, high cost of microbial enumeration instruments obstructs the growth of the market. Increasing preference for contract manufacturing and emerging economies are creating opportunities in the market.

Enquire about report: https://www.alliedmarketresearch.com/purchase-enquiry/928

The prominent companies operating in the market are Charles River Laboratories International Inc., Sigma-Aldrich Corporation, SGS S.A., Wuxi Pharmatech (CAYMAN) Inc., Merck & Co. Inc., Becton, Dickinson, and Company, North American Science Associates Inc., Nelson Laboratories Inc., Pacific Biolabs, and ATS Labs Inc. They have formulated strategies such as partnerships, collaborations, mergers & acquisitions, joint ventures, expansions, and others to sustain in the market.

Browse complete report: https://www.alliedmarketresearch.com/bioburden-testing-market

KEY BENEFITS FOR STAKEHOLDERS:

  • The report offers a detailed analysis of key driving and restraining factors of the world bioburden testing market.
  • The report provides an extensive analysis of current and future market status of the world bioburden testing market.
  • This report offers an in-depth quantitative analysis of the current market and estimations through 2015-2020, which assists in identifying the prevailing market opportunities.
  • An exhaustive analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
  • Comprehensive analysis has been done in this report by constructing market estimations for the key market segments between 2015 and 2020.
  • An extensive analysis of current research and clinical developments withinthe world bioburden testing market is provided with key market dynamic factors that help in understanding the behaviour of the market.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Growth Drivers Overview in the Acute Ischemic Stroke Diagnosis and Treatment Market by 2022

Posted on Updated on

www.alliedmarketresearch.com Include New Market Research Report “World Acute Ischemic Stroke Diagnosis and Treatment Market” Attractiveness, Competitive Landscape and Forecasts to Its Huge Collection Of Research Reports.

Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. Heart attacks and strokes respectively account for the highest number of deaths due to cardiovascular diseases, globally. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Stroke is one of the leading cause of long term disability, occurring at a higher rate in the old age population. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

Request sample report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1440

The two major factors propelling the growth of the acute ischemic stroke diagnosis and treatment market are; large patient pools and a concerning rise in population at a higher risk of developing stroke in the near future. Rising incidence of diabetes along with heavy tobacco users and an increase in the ageing population are significant factors that determine the market growth. However, the high cost of treatment, lack of transparent reimbursement policies, and limited availability of expertise; are likely to restrict the market growth.

Enquire about report: https://www.alliedmarketresearch.com/purchase-enquiry/1440

The global ischemic stroke diagnosis and treatment market is segmented on the basis of type and geography. According to type, the market is segmented into, diagnostics and therapeutics. The diagnostic market is further segmented into Computed Tomography Scan (CT scan), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and Blood tests. The therapeutic market further segments into Tissue Plasminogen Activator Anticoagulant, Antiplatelet and Antihypertensive. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.

Connect to Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/1440

New Product launches and collaborations are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery through a minimally invasive technique. NeuroVive Pharmaceutical AB, entered into collaboration with BBB Therapeutics, for development of the NVP014 drug candidate used in the treatment of ischemic strokes.

The companies profiled in this report include, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, Stryker Corporation, Genentech, Inc. and Merck & Co., Inc.

Browse full report @ https://www.alliedmarketresearch.com/acute-ischemic-stroke-diagnosis-and-treatment-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Human Insulin Market: Segmentation & Coverage

Posted on Updated on

www.alliedmarketresearch.com Include New Market Research Report “Human Insulin Market” Attractiveness, Competitive Landscape and Forecasts to Its Huge Collection Of Research Reports.

Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities. Competitive landscape section focuses on key leaders within the global human insulin market and their major growth strategies. Detailed analysis of segments helps in understanding market dynamics and would be beneficial for market professionals.

Request sample report @ https://www.alliedmarketresearch.com/request-toc-and-sample/417

The growth of global human insulin market is primarily attributed to rising prevalence of diabetes. The factors that contribute to growing number of diabetic patient globally include changes in lifestyles, growing number of obese as well as geriatric population and inadequate healthcare services. Favorable government policies and technological advances such as innovation of insulin pens have also fueled the growth of this market. However, cost of production, manufacturing complexities and critical regulatory requirements for the approval of biotechnology derived products are the factors that could hinder the growth of global human insulin market. Pipeline insulin products and untapped emerging economies are the promising opportunities for the manufacturers of global human insulin.

Enquire for customization of report: https://www.alliedmarketresearch.com/request-for-customization/417

Global Human Insulin Market by Types: The global human insulin market is segmented by product type into Traditional and Modern Human Insulin. Traditional Human Insulin is segmented as Premixed, Intermediate Acting and Short Acting Human Insulin, whereas Modern Human Insulin includes Premixed, Long Acting and Rapid Acting types. Long acting modern insulin and premixed modern insulin are the fastest growing categories of this segment.

Send Enquiry About Report: https://www.alliedmarketresearch.com/purchase-enquiry/417

Global Human Insulin Market by Brands: According to the brands available into the market, the global human insulin market is classified as traditional and modern human insulin brands. Traditional brands include Humulin, Actrapid and Insuman, whereas, modern brands include Humalog, Novomix, Novorapid, Lantus, Levemir and Apidra. Over the past few years, biosimilars has gained popularity in comparison to branded drugs. Basalog, Wosulin and Glaritus are the biosimilars available in Asia-Pacific region. Amongst traditional and modern brands, Lantus holds the largest market share, whereas, Levemir and Apidra are the fastest growing insulin drugs.

Browse full report @ https://www.alliedmarketresearch.com/human-insulin-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Human Insulin

Spa Service Market to Reach $154.6 Billion, Worldwide by 2022

Posted on Updated on

Global Spa Services Market projects that the market would reach $154.6 billion by 2022. Medical spa is expected to register the fastest growth, during 2016-2022, according to new research published by Allied Market Research. Europe accounted for the largest market share of about 39.1%, followed by Asia-Pacific and North America, in 2015. LAMEA region is expected to witness the highest growth, owing to rising investments into tourism industry in countries such as Brazil and UAE.

Access Full Summary of Spa Service Market: https://www.alliedmarketresearch.com/spa-market

Growth of the market is fostered by factors such as increasingly hectic lifestyles, rising wellness tourism, rising demand from teenagers and improving standards of living. Moreover, increase in population of working women and rising popularity of spa among male customers is also supplementing the growth of world spa services market. However, scarce availability of skilled labor and lesser penetration in underdeveloped regions limit the market growth to a certain extent. Furthermore, the cost of employing skilled labor in the world spa services market is high, thereby adding to the operation costs incurred by the firms.

spa1

The salon spa segment accounted for the largest market share of around 41.8% in 2015. Increase in disposable income among the middle-income class, affordable services, and innovative marketing strategies used by salons contribute to the growth of this segment. However, the highest CAGR of 10.7% is expected to be witnessed by the medical spa segment during the forecast period. Technological advancement in medical treatments such as laser technology, dermal fillers, cellfina, ultratherapy and others are driving the demand for medical spa. Hotel spa and destination spa would also witness notable growth during the forecast period, owed to massive investments in tourism infrastructure in Asia and Middle East.

The world spa services market was dominated by Europe in 2015, owed to higher demand in Western European countries such as Germany, France, UK and others. In addition, extensive demand arising from Eastern Europe countries due to rising income of middle class customer groups has also contributed significantly to the market growth. Asia-Pacific is the second largest region in the world spa services market owed to huge contribution by countries such as Japan and China, which are highly concentrated with mineral spa. Growth in Asia-Pacific market would also be fostered by booming hospitality industry and the rising popularity of traditional spas such as Ayurvedic and Thai massage in the region.

LAMEA region is expected to witness the fastest growth, with a CAGR of 10.0% during the forecast period, owing to rising investments in tourism industry in countries such as Brazil and UAE. The tourism sector in Brazil is attaining more proficiency and professionalism posing huge avenues for the world spa services market to expand in future.

Request for Sample Report : https://www.alliedmarketresearch.com/request-free-sample/1502

Key Findings of Spa Services Market Study:

• Europe was the highest revenue-generating region in the world spa services market in 2015.

• LAMEA is anticipated to witness the highest CAGR during the forecast period.

• Salon spa was the largest revenue-generating segment in 2015.

• Medical spa is anticipated be the fastest growing spa segment due to rapid advancements in medical field.

• The report provides actual historical figures for 2014 and 2015 and provides Y o-Y forecasts for 2016 to 2022, considering 2015 as base year.

Key companies profiled in this report include Four Seasons Hotel Limited, Emirates Palace, Trailhead Spa, Jade Mountain Resort, Massage Envy Franchise LLC, Six Senses Hotels Resorts Spas, Clarins Day Spa, Belmond Maroma Resort & Spa, Lanserhof Tegernsee Spa, and Gaia Retreat & Spa.

Arthroscopy Devices Market Expected to Reach $5,334 Million, Globally, by 2022

Posted on Updated on

Arthroscopy Devices Market Report, published by Allied Market Research, forecasts that the global market was valued at $3,453 million in 2015 and is projected to reach $5,334 million by 2022, growing at a CAGR of 6.2% from 2016 to 2022. The arthroscopic implants segment held nearly two-fifths of the total market in 2015.

Arthroscopy is a minimally invasive surgical procedure that helps surgeons examine and treat bone and joint related problems using an arthroscope and other arthroscopy devices (such as visualization systems, arthroscopic implants, power shaver systems, radiofrequency devices, and others). They are essential to diagnose and treat osteoarthritis, rheumatoid arthritis, carpal tunnel syndrome, bone tumor, and others. The market for arthroscopy devices has grown tremendously in the recent years due to increase in number of sport injuries, rapid ageing population and increase in patient preference for minimally invasive surgeries.

Read full summary of the report at: https://www.alliedmarketresearch.com/arthroscopy-devices-market

Key factors that boost the growth of global arthroscopy devices market are the benefits of arthroscopy devices including shorter recovery time, minimal post-operative complications, and greater precision to perform surgeries of highly sensitive areas such as spine. In addition, upsurge in obesity rate causing bone degradation in population and the rise in demand for arthroscopic treatment in emerging economies offer lucrative opportunities for the growth of this market. However, dearth of skilled professionals and high costs associated with arthroscopic devices especially the novel implants (biodegradable and 3D implants) impede the market growth.

arthroscopy

Arthroscopic implants is anticipated to dominate the arthroscopy devices market throughout the analysis period accounting for over two-fifths of the total share in 2015. This is owing to the rapid adoption attributed by the fact that implants mimic real joint-movement and are imperative in supporting damaged bone by facilitating faster joint recovery.

Visualization systems segment is expected to be the fastest growing sector of the market owing to the incorporation of advanced technologies in visualization systems, for instance, arthroscopic cameras embedded with ultra-high definition and 4-light emitting diode (LED) multi-light technology, which enhances the video quality. The global visualization system market is expected to grow at a CAGR of 8.2% from 2016 to 2022.

Spine arthroscopy dominated the application segment with about two-sevenths share in 2015 growing at a CAGR of 6.2% from 2016 to 2022. Growth in number of spine ailments such as degenerative conditions of the spine, spine trauma, tumors, spinal deformity, and infection of the spine amongst all age groups drives the market growth.

Key findings of the Arthroscopy Devices Market:

  • The knee arthroscopy market is anticipated to witness the fastest growth rate during 2016-2022.
  • Visualization systems is projected to be the fastest growing segment during the analysis period.
  • Knee implants dominated the arthroscopic implants market, and is expected to grow at a CAGR of 5.2% during the forecast period.
  • North America dominated global arthroscopy devices market and is projected to grow at a CAGR of 5.4%.
  • Spine arthroscopy application occupied nearly two-sevenths of the total market in 2015.
  • India is the fastest growing country in Asia-Pacific region, registering a CAGR of 9.0% from 2016 to 2022.

In 2015, Asia-Pacific and LAMEA collectively accounted for one-fourth share of the total arthroscopy devices market and this trend is expected to continue due to rise in geriatric population & targeted diseases, specifically in China and India with large and other developing economies of the regions. Rise in sports as a career, surge in disposable income, improvement in healthcare funding, and high populace demanding more arthroscopic procedures fuel the growth of the arthroscopy devices market in the Asia-Pacific region.

The major companies profiled in the report include Arthrex, Inc. Conmed Corporation, Johnson & Johnson, KARL STORZ GmbH & Co. KG, Medtronic, Plc, Richard Wolf GmbH, Smith & Nephew, Plc, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.

Connect to Analyst at: https://www.alliedmarketresearch.com/connect-to-analyst/426